Location: Colorado Springs
Ages: Healthy infants between 29 weeks and 34 weeks
Compensation: Up to $555
Smokers Allowed: No
The purpose of this study is to evaluate how effective MEDI8897 is at preventing lung disease caused by RSV and to evaluate the safety and tolerability of MEDI8897 in healthy preterm infants compared with placebo. The study will also measure drug levels of MEDI8897 in the blood, as well as looking at days missed from work and daycare.